Key facts
- This page summarizes Kumud Kalia's Form 4 filing for Guardant Health, Inc. (GH).
- 14 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 05 Mar 2026, 17:44.
Kumud Kalia - 04 Mar 2026 Form 4 Insider Report for Guardant Health, Inc. (GH)
- Reporting relationship
- Chief Information Officer
- Issuer ticker
- GH
- Reported as of
- 04 Mar 2026
- Net transaction value
- -$3,812,661
- SEC form
- 4
- Accepted by SEC
- 05 Mar 2026, 17:44:17 UTC
- Prior SEC filing
- 05 Jan 2026
- Next SEC filing
- 13 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ John G. Saia, as attorney-in-fact for Kumud Kalia
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Kumud Kalia filed Form 4 for Guardant Health, Inc. (GH) on 05 Mar 2026.
Change
- Previous filing in this sequence was filed on 05 Jan 2026.
- Current net transaction value: -$3,812,661.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001927831
Primary reporting owner
Kalia Kumud
- Relationship
- Chief Information Officer
- Address
- 3100 HANOVER STREET, PALO ALTO
- Signature
- /s/ John G. Saia, as attorney-in-fact for Kumud Kalia
- Signature date
- 05 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GH
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +2,119
- Change %
- +6.1%
- Price
- $47.20*
- Shares after
- 36,643
- Date
- 04 Mar 2026
- Ownership
- Direct
GH
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +15,000
- Change %
- +41%
- Price
- $47.20*
- Shares after
- 51,643
- Date
- 04 Mar 2026
- Ownership
- Direct
GH
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +1,000
- Change %
- +1.9%
- Price
- $74.00*
- Shares after
- 52,643
- Date
- 04 Mar 2026
- Ownership
- Direct
GH
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +5,000
- Change %
- +9.5%
- Price
- $32.86*
- Shares after
- 57,643
- Date
- 04 Mar 2026
- Ownership
- Direct
GH
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +10,000
- Change %
- +17%
- Price
- $28.37*
- Shares after
- 67,643
- Date
- 04 Mar 2026
- Ownership
- Direct
GH
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +10,000
- Change %
- +15%
- Price
- $28.61*
- Shares after
- 77,643
- Date
- 04 Mar 2026
- Ownership
- Direct
GH
transaction
Common Stock
Sale
- Transaction value
- $2,566,311
- Shares
- -26,980
- Change %
- -35%
- Price
- $95.12
- Shares after
- 50,663
- Date
- 04 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
GH
transaction
Common Stock
Sale
- Transaction value
- $1,246,350
- Shares
- -13,020
- Change %
- -26%
- Price
- $95.73
- Shares after
- 37,643
- Date
- 04 Mar 2026
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GH
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -2,119
- Change %
- -4.1%
- Price
- $0.000000*
- Shares after
- 49,305
- Date
- 04 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,119
- Exercise price
- $47.20
- Footnotes
- F3
GH
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -15,000
- Change %
- -30%
- Price
- $0.000000*
- Shares after
- 34,305
- Date
- 04 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,000
- Exercise price
- $47.20
- Footnotes
- F3
GH
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -1,000
- Change %
- -3.5%
- Price
- $0.000000*
- Shares after
- 27,670
- Date
- 04 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,000
- Exercise price
- $74.00
- Footnotes
- F4
GH
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -5,000
- Change %
- -44%
- Price
- $0.000000*
- Shares after
- 6,414
- Date
- 04 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,000
- Exercise price
- $32.86
- Footnotes
- F5
GH
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -10,000
- Change %
- -52%
- Price
- $0.000000*
- Shares after
- 9,410
- Date
- 04 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $28.37
- Footnotes
- F6
GH
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -10,000
- Change %
- -28%
- Price
- $0.000000*
- Shares after
- 25,721
- Date
- 04 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $28.61
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $94.460 to $95.455. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F2
Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $95.46 to $96.14. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F3
This represents a stock option award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on November 7, 2023 and the remaining 75% of the shares vests in equal monthly installments over the remaining three-year period thereafter.
Footnote F4
This represents a stock option award granted on April 20, 2020 that vests over a four-year period. 25% of the shares subject to such award vested on January 7, 2021 and the remaining 75% of the shares vested in equal monthly installments over the three-year period thereafter.
Footnote F5
This represents a stock option award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 9, 2024 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.
Footnote F6
This represents a stock option award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.
Footnote F7
This represents a stock option award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.